Sensitivity
81 percent
- EndpointLow-bone-density flag sensitivity against the regulatory reference
- Population371 CT studies from 4 geographically diverse sites
- Tested versionBunkerHill BMD; FDA submission K242295
Authorized purpose: Analyzes existing CT images in DICOM format from adults aged 30 years and older to estimate average areal BMD of spinal bones and flag low bone density below a preset threshold, including opportunistic scans without a phantom; it does not replace DXA or other dedicated BMD testing.
Overview status: Source-reviewed overview
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
Clinical takeaway. Clinical role: Analyzes existing CT images in DICOM format from adults aged 30 years and older to estimate average areal BMD of spinal bones and flag low bone density below a preset threshold, including opportunistic scans without a phantom; it does not replace DXA or other dedicated BMD testing.
Evidence takeaway. Evidence from the reviewed source record: Study type: Stand-Alone Performance. Cases: 371. Sites: 4. Reported sensitivity: 81% (95% CI: 74%, 86.8%). Reported specificity: 78.4% (95% CI: 72.3%, 83.7%)
Evidence context not reviewed for this FDA record.
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Exact clinical-use normalization from the FDA packet; this text is also the locked corrections value.
Packet wording: "The Bunkerhill BMD Algorithm is a post-processing AI-powered software intended for adults 30 years and above to assess estimated DXA-measured average areal bone mineral density of spinal bones from existing CT scans and outputs a flag for low bone density below a pre- specified threshold." … "It is not intended to replace DXA or any other tests dedicated to BMD measurement.". Read from the exact FDA decision document on 2026-11-14.
Packet wording: "The Bunkerhill BMD Algorithm is a post-processing AI-powered software intended for adults 30 years and above to assess estimated DXA-measured average areal bone mineral density of spinal bones from existing CT scans" … "Both devices analyze computed tomography (CT) images that are sent to the software in DICOM format.". Read from the exact FDA decision document on 2026-11-14.
Clinical output reported in the exact-submission ACR model card.
Patient-population text reported in the exact-submission ACR model card; institutional setting may still require vendor confirmation.
Intended-user text reported in the exact-submission ACR model card.
Exact-product limitations and clinician-review boundary from the FDA packet.
Structured study metadata from the exact-submission ACR model card; this is not an independent evidence synthesis.
Evidence
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Structured study metadata from the exact-submission ACR model card; this is not an independent evidence synthesis.
Model sensitivity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.
Model specificity reported by ACR AI Central. Review endpoint, threshold, study population, and tested version before comparison.
81 percent
78.4 percent
K242295
ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.
Safety and lifecycle
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Price not public here; enter your quote
Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Source context, not route validation: Existing CT scans of adults 30 years and above, sent to the software in DICOM format and analyzed for spinal bone mineral density, including CT scans acquired for other purposes.
Scope: Exact FDA submission. Packet wording: "The Bunkerhill BMD Algorithm is a post-processing AI-powered software intended for adults 30 years and above to assess estimated DXA-measured average areal bone mineral density of spinal bones from existing CT scans" … "Both devices analyze computed tomography (CT) images that are sent to the software in DICOM format.". Read from the exact FDA decision document on 2026-11-14.
Confirm scanner/model, protocol, series completeness and both software builds.
Field checked 2026-11-14 · FDA 510(k) decision material K242295: BunkerHill BMD
Source context, not route validation: The exact-submission ACR model card explicitly references DICOM in the described input, output, or workflow; exact interfaces, versions, and local compatibility require confirmation.
Scope: Exact FDA submission. Interoperability terms explicitly reported in the exact-submission ACR model card; interface versions and local compatibility still require confirmation.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Field checked 2026-09-01 · BunkerHill BMD model card (K242295)
Unresolved route: Not established for the exact route.
Scope: Exact FDA submission. The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-10-27 ·
Source context, not route validation: The device outputs an estimated DXA-measured average areal bone mineral density of spinal bones, a flag for low bone density below a pre-specified threshold, a calibrated BMD score, and a T-score group. Results can be copied to clipboard, inserted in report, or output as DICOM Secondary Capture.
Scope: Exact FDA submission. Clinical output reported in the exact-submission ACR model card.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Field checked 2026-09-01 · BunkerHill BMD model card (K242295)
Unresolved route: The device outputs an estimated DXA-measured average areal bone mineral density of spinal bones, a flag for low bone density below a pre-specified threshold, a calibrated BMD score, and a T-score group. Results can be copied to clipboard, inserted in report, or output as DICOM Secondary Capture.
Scope: Exact FDA submission. Clinical output reported in the exact-submission ACR model card.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Field checked 2026-09-01 · BunkerHill BMD model card (K242295)
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
No tests below have been performed or accepted.
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Interoperability terms explicitly reported in the exact-submission ACR model card; interface versions and local compatibility still require confirmation.
Vendor statement, not an attestation; exact-release scope is not established.
DICOM is explicitly referenced in the described input, output, or workflow.
exact submission · checked 2026-09-01The model card does not establish every supported DICOM object, transfer method, or local interface.
The official Bunkerhill BMD page describes use of existing non-contrast abdominal CT without additional imaging hardware, a calibration phantom, or additional radiation.
product family · checked 2026-09-06Exact FDA labeling controls supported CT inputs and patient criteria.
The official page describes integration within the Bunkerhill Carebricks platform to support follow-up care navigation after a low-density flag.
product family · checked 2026-09-06Family-platform statement; interface and local implementation terms require confirmation.
Regulatory identity
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Imaging modality reported in the exact-submission ACR AI Central model card.
Anatomy normalized from explicit exact-submission ACR model-card wording.
Research record
This audit distinguishes completed source review from fields that have not yet been researched.
Stored exact-submission candidate metadata had zero PubMed and ClinicalTrials.gov identifiers; this metadata screening is not a full paper or registry-record review. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor documentation, vendor product page, literature index, trial registry, pubmed, clinical trials, openfda device recall
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Official non-FDA product sources were reviewed for buyer and workflow context, but no exact-submission amount, currency, unit, term, or implementation fee was displayed. A vendor quote remains required.
Bounded web search on 2026-10-26 (query: "Bunkerhill BMD reimbursement CPT CMS"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. The Bunkerhill clearance page was read and states no coding or payment; CMS bone mass measurement policies surfaced as general results and are not bound to this product. This records what was found, not that none exists.
The reviewed sources do not establish the current exact-release hosting topology, data flow, region, tenancy, or disaster-recovery configuration.
Training, onboarding, competency, and support commitments are commercial implementation details that require current vendor documentation.
Local acceptance testing, production monitoring, drift review, update control, and incident escalation require a current vendor and site-specific governance plan.
9 sources - 3 history items
Scope: regulatoryIdentity, purpose, modality, anatomy
Scope: regulatoryIdentity, modalityContext
Scope: purpose, modality, intendedUsers, careSetting, output, reportedSensitivity, reportedSpecificity, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities
Scope: evidenceDiscovery
Scope: evidenceDiscovery, studyStatus
Scope: recallDiscovery, nativeSubmissionMatching
Scope: identity, clinical, evidence, implementation
Scope: buyer_workflow, clinical, implementation
Scope: security
Regulatory record
510(k)
Research record
human reviewed
Editorial review
Source-reviewed editorial overlay
Alternatives
Agada Medical, Ltd.
Authorized purpose: Auto-Seg and Spine Auto-Seg accept spine and pelvis CT images and provide three-dimensional segmentation and labels to support spine-surgery planning and assessment by spine surgeons.
GE Medical Systems SCS
Authorized purpose: Use with CT images to automatically generate anatomically focused multi-planar spine reformats, apply vertebral-body and intervertebral-disc labels, and export the results to predetermined DICOM destinations for review.
Siemens Medical Solutions USA, Inc.
AI-Rad Companion (Musculoskeletal) is an image processing software that provides quantitative and qualitative analysis from previously acquired Computed Tomography DICOM images to support radiologists and physicians from emergency medicine, specialty care, urgent care, and general practice in the evaluation and assessment of musculoskeletal disease. It provides the following functionality: • Segmentation of vertebras • Labelling of vertebras • Measurements of heights in each vertebra and indication if they are critically different • Measurement of mean Hounsfield value in volume of interest within vertebra. Only DICOM images of adult patients are considered to be valid input.
Siemens Medical Solutions USA, Inc.
Authorized purpose: Provides quantitative and qualitative analysis of previously acquired CT DICOM images to support radiologists and physicians in musculoskeletal-disease assessment.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Open existing correction destinationPermission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.
Correction policy and limits · Public repository change history